Revised December 20, 2005

Objective 3.1
For 100% of health-system patients, pharmacists will be actively involved in ensuring that they receive evidence-based medication therapy.

Baseline 74.2%

Crosswalk Resources

1. JCAHO (MM.2.1, MM.3.1, MM.8.1)
2. Center for Education and Research on Therapeutics (CERTS)
3. National Guideline Clearinghouse (NGC)
4. Agency for Health Research & Quality (AHRQ)
5. Cochrane Collaboration
6. National Library of Medicine
7. Supporting Literature - References 1, 39 

Objective 3.2
In 100% of health systems, pharmacists will be actively involved in the development and implementation of all evidence-based therapeutic protocols involving medication use.

Baseline  95.3% (95% CI, 92.6–97.0%)

Crosswalk Resources

1. JCAHO (MM.2.1)
2. Supporting Literature - References 1, 34, 38, 39 

Objective 3.3
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction or congestive heart failure will receive angiotensin-converting enzyme inhibitors or angiotensin receptor blockers at discharge.

Baseline 19.7% (95% CI, 15.9–24.0%)

Crosswalk Resources

1. CMS/JCAHO (revised measure)
2. Core Measures 
3. American College of Cardiology 
4. American Heart Association
5. National Committee for Quality Assurance
6. IOM 
7. Supporting Literature - References 1, 13, 14, 40-45  

Objective 3.4
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive beta-blockers at discharge.

Baseline 17.2% (95% CI, 13.7–21.4%)

Crosswalk Resources

1. Core Measures 
2. American College of Cardiology
3. American Heart Association
4. National Committee for Quality Assurance
5. IOM 
6. Supporting Literature - References 1, 40, 41, 43, 45-47 

Objective 3.5
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive aspirin at discharge.

Baseline 18.1% (95% CI, 14.5–22.5%)

Crosswalk Resources

1. Core Measures 
2. American College of Cardiology
3. American Heart Association
4. IOM 
5. Supporting Literature - References 1, 40, 41, 45, 48, 49  

Objective 3.6
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive lipid-lowering therapy at discharge.

Baseline 10.5% (95% CI, 7.8–13.9%)

Crosswalk Resources 

1. Core Measures 
2. National Cholesterol Education Program
3. National Committee for Quality Assurance
4. American Diabetes Association
5. Supporting Literature - Reference 1, 26, 41, 50-54 

Objective 3.7
90% of health-system pharmacies will participate in ensuring that nonhospitalized patients who are receiving medications to decrease blood glucose levels will be assessed annually with a HbA1c test.

Baseline 3.9% (95% CI, 2.3-6.7%)

Note: 23.5% of hospitals have such a program (95% CI, 18.6-29.3%), but only 16.17% (95% CI, 9.6-27.6%) have pharmacy participation.

Crosswalk Resources

1. American Diabetes Association
2. American Association of Clinical  Endocrinologists
3. National Committee for Quality Assurance
4. Supporting Literature - References 11, 55-57